Skye Bioscience extends merger Outside Date with Emerald Health to Oct 15, 2022; adjusts meeting timeline for SEC review

Skye Bioscience, Inc.

Outside Date extended to October 15, 2022; auto-extends to Nov 15 if SEC reviews proxy statement.
Shareholder meeting must be held by Oct 4 (no SEC review), Nov 4 (SEC review), or Nov 14 (amendments required).
Second amendment to Arrangement Agreement dated May 11, 2022; parties may further extend Outside Date by 45 days.
Extension conditioned on satisfaction of certain closing conditions and regulatory approvals not yet obtained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.